Lv11
50 积分 2022-03-09 加入
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
1小时前
待确认
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
1小时前
已完结
Zanubrutinib-associated ecchymotic lesions
6个月前
已关闭
Primary endometrial natural killer (NK)/T cell lymphoma: case report and review of literature
6个月前
已关闭
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
7个月前
已完结
Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
11个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
11个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
1年前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
1年前
已完结
Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy
1年前
已完结
皖公网安备34019202002308
